0001104659-16-095427.txt : 20160210
0001104659-16-095427.hdr.sgml : 20160210
20160210143402
ACCESSION NUMBER: 0001104659-16-095427
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160210
DATE AS OF CHANGE: 20160210
EFFECTIVENESS DATE: 20160210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 161405012
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
12-31-2015
12-31-2015
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
415-801-8100
/s/ Robin L. Praeger
San Francisco
CA
02-09-2016
0
7
170904743
false
INFORMATION TABLE
2
a16-3834_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
14259560
407416
SH
OTR
0
407416
0
Five Prime Therapeutics, Inc.
Common Stock
33830X104
45324308
1092152
SH
OTR
0
1092152
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
1772135
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
7353812
1281152
SH
OTR
0
1281152
0
Biotie Therapies Corp.
ADS
09074D103
3855443
268672
SH
OTR
0
268672
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
20758148
2215384
SH
OTR
0
1281152
0
Glaukos Corporation
Common Stock
377322102
77581337
32016637
SH
OTR
0
268672
0